Literature DB >> 13000410

Liver catalase activity in parabiotic rats with one partner tumor-bearing.

B LUCKE, M BERWICK, I ZECKWER.   

Abstract

Entities:  

Keywords:  LIVER/neoplasms; NEOPLASMS/metabolism; OXIDASES

Mesh：

Substances：

Year:  1952        PMID： 13000410

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  [Effect of tumor tissue decoction on activity of leukocyte catalase].

Authors:  W FRISCH-NIGGEMEYER; H HOLLER
Journal:  Z Krebsforsch       Date:  1955

2.  [Effect of the pituitary-gonad system function on Ehrlich ascites carcinoma].

Authors:  G DORNER
Journal:  Z Krebsforsch       Date:  1957

3.  [Correlated decrease of manganese and catalase in liver. Investigations in rats bearing Yoshida-sarcomas and in mice injected with tumour and tissue extracts (author's transl)].

Authors:  J Zimmerer; H Wesch; K Wayss; M Volm
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973

4.  Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia.

Authors:  L Tessitore; G Bonelli; F M Baccino
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

5.  Isolation of a glycoprotein responsible for the enhanced concanavalin A agglutinability of erythrocytes in Yoshida-ascites-sarcoma-bearing rats: the mechanism of paraneoplastic syndromes.

Authors:  R D Kalraiya; A Sanjay; N G Mehta
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

6.  Purification of ornithine decarboxylase-inducing factor from cell-free ascites fluid of Ehrlich ascites tumor and its characteristics.

Authors:  K Imamura; Z Y Wang; K Murayama-Oda; H K Kim; T Tsuji; T Tanaka
Journal:  Jpn J Cancer Res       Date:  1991-03

7.  Catalase activity of liver and kidney in frogs with spontaneous renal carcinoma.

Authors:  B LUCKE; M BERWICK
Journal:  J Exp Med       Date:  1954-08-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.